AAAAAA
Results:
1-14
|
Results: 14
Authors:
Holgate, ST
Banik, AN
Citation: St. Holgate et An. Banik, Epidemiology of asthma, LUNG BIOL H, 139, 2000, pp. 1-26
Authors:
Sterk, PJ
Citation: Pj. Sterk, Pathophysiology of asthma, LUNG BIOL H, 139, 2000, pp. 27-56
Authors:
Djukanovic, R
Citation: R. Djukanovic, Pathology of asthma, LUNG BIOL H, 139, 2000, pp. 57-84
Authors:
Fryer, AD
Costello, RW
Citation: Ad. Fryer et Rw. Costello, Muscarinic receptor subtypes and anticholinergic therapy, LUNG BIOL H, 139, 2000, pp. 85-118
Authors:
Beasley, R
Crane, J
Burgess, CD
Citation: R. Beasley et al., Long-acting beta(2)-agonist drugs, LUNG BIOL H, 139, 2000, pp. 119-154
Authors:
Spahn, JD
Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Inhaled glucocorticoids, established and new, LUNG BIOL H, 139, 2000, pp. 155-181
Authors:
Agrawal, DK
Townley, RG
Citation: Dk. Agrawal et Rg. Townley, Platelet-activating factor antagonists in bronchial asthma, LUNG BIOL H, 139, 2000, pp. 183-202
Authors:
Joos, GF
Advenier, C
Citation: Gf. Joos et C. Advenier, Tachykinin receptor antagonists, LUNG BIOL H, 139, 2000, pp. 203-235
Authors:
Hughes, B
Higgs, G
Citation: B. Hughes et G. Higgs, Therapeutic potential of phosphodiesterase type 4 inhibitors in the treatment of asthma, LUNG BIOL H, 139, 2000, pp. 237-284
Authors:
Sampson, AP
Diamant, Z
Citation: Ap. Sampson et Z. Diamant, Leukotriene modulators, LUNG BIOL H, 139, 2000, pp. 285-328
Authors:
Fahy, JV
Citation: Jv. Fahy, The anti-IgE treatment strategy for asthma, LUNG BIOL H, 139, 2000, pp. 329-342
Authors:
Boonstra, A
Savelkoul, HFJ
Citation: A. Boonstra et Hfj. Savelkoul, Activity of T-cell subsets in allergic asthma, LUNG BIOL H, 139, 2000, pp. 343-360
Authors:
Barnes, PJ
Citation: Pj. Barnes, New targets for future asthma therapy, LUNG BIOL H, 139, 2000, pp. 361-389
Authors:
Kips, JC
Pauwels, RA
Citation: Jc. Kips et Ra. Pauwels, Current practice and future trends in clinical trials in asthma, LUNG BIOL H, 139, 2000, pp. 391-403
Risultati:
1-14
|